Abilify (aripiprazole) is the first antipsychotic approved for major depressive disorder

Abilify (aripiprazole) is the first antipsychotic approved for major depressive disorder...not just bipolar disorder.

It'll be added to antidepressants to augment their effects.

More than half of patients still have symptoms after starting an antidepressant. If symptoms persist after 4 to 8 weeks, consider switching to another antidepressant...combining antidepressants...or adding a different type of drug to boost efficacy.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote